Hims & Hers, a tele-health start-up, aims to stand apart from dozens of Super Bowl commercials hawking snacks with a spot ...

For its most recently reported quarter (Q3 of 2024), Hims & Hers generated $401.6 million in revenue. That resulted in a free ...

The Super Bowl spot is part of a larger campaign as Hims & Hers continues to highlight its weight loss treatments. The ad ...

Telehealth provider will make its big game debut as the semaglutide shortage continues to sustain the firm’s lower-priced ...

A multi-million dollar Super Bowl ad from telehealth company Hims and Hers downplays risks and side effects of compounded ...

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, ...

Hims & Hers’ decision to advertise at the Super Bowl represents an ambitious play for the brand as it positions itself in the ...

Type a few symbols and Take a Trial. The signals for these will appear immediately on your My Stocks Page; add more too.

Hims & Hers Health Inc (HIMS) stock saw a decline, ending the day at $30.51 which represents a decrease of $-0.36 or -1.17% from the prior close of $30.87. The stock opened at $29.28 and touched a low ...

Discover why Hims & Hers Health is a top telehealth leader with impressive growth potential and a promising future for ...

Financial writer highlights undervalued Hims & Hers Health with impressive growth potential and innovative product launches, ...

Telehealth company's spot decries medications from others as "priced for profits, not patients," while its own weight-loss drugs are "affordable." ...